Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
Launched by LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE · Jan 23, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Healthy Mums, Healthy Babies," is studying the effects of providing multiple micronutrient supplementation (MMS) compared to traditional iron-folic acid supplementation (IFA) during pregnancy in Ethiopia. Researchers want to find out if switching to MMS can help improve the birthweight of newborns. Previous studies suggest that babies born to mothers who take MMS may weigh more at birth than those whose mothers take IFA. By gathering evidence from this trial, the Ethiopian Ministry of Health aims to make informed decisions about possibly using MMS more widely in the future.
Women aged 15 to 49 who give birth in participating health facilities and agree to take part in the study can be included. Participants will receive either MMS or IFA as part of their routine antenatal care, and the main focus will be on measuring the birthweight of their babies. Additionally, the study will explore how acceptable mothers find MMS, how well they stick to taking the supplements, and any challenges with implementing this new approach. Overall, the findings from this trial will help improve maternal and newborn health in Ethiopia and contribute to global knowledge about the benefits of MMS during pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • For the primary outcome, mothers who deliver a liveborn child in enrolled health facilities and who are willing/consent to participate in the study.
- • For the secondary objectives, all antenatal care staff and women attending for routine antenatal care during the survey periods will be included.
- Exclusion Criteria:
- • For the primary outcome, stillbirths will be excluded. Data for any newborn who subsequently dies while still in the facility will be excluded from all secondary analyses.
About London School Of Hygiene And Tropical Medicine
The London School of Hygiene and Tropical Medicine (LSHTM) is a prestigious research institution renowned for its leadership in global health and infectious disease research. Committed to advancing public health through innovative research and education, LSHTM conducts a wide array of clinical trials aimed at improving health outcomes in diverse populations. With a multidisciplinary team of experts, LSHTM leverages cutting-edge methodologies and collaborative partnerships to address pressing health challenges, particularly in low- and middle-income countries. The institution's dedication to evidence-based solutions underscores its pivotal role in shaping health policies and practices worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Addis Ababa, , Ethiopia
Itang, Gambella Region, Ethiopia
Gīmbīcho, Oromia Region, Ethiopia
Bona Gena, Sidama Region, Ethiopia
Dara, Snnpr Region, Ethiopia
Aware, Somali Region, Ethiopia
Patients applied
Trial Officials
Tanya Marchant, PhD
Principal Investigator
London School of Hygiene and Tropical Medicine
Masresha Tessema, PhD
Study Director
Ethiopian Public Health Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials